This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: University of Washington, Icos Corporation, Vanderbilt University. Active years: 1997-2000.
Company Filing History:
4 out of 2,165 
3 out of 164 
3 out of 1,218 
Years Active: 1997-2000
Title: Ann Kadlecek: Innovator in cGMP-specific Phosphodiesterase Research
Introduction
Ann Kadlecek is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biochemistry, particularly in the area of cyclic GMP-binding and cyclic GMP-specific phosphodiesterase materials. With a total of 4 patents to her name, her work has advanced our understanding of enzymatic activity modulation.
Latest Patents
Among her latest patents, Ann has developed novel purified and isolated nucleotide sequences encoding the cGMP-binding, cGMP-specific phosphodiesterase designated cGB-PDE. This invention provides methods and materials for the recombinant production of cGB-PDE polypeptide products. Additionally, it includes methods for identifying compounds that modulate the enzymatic activity of cGB-PDE polypeptides. Another significant patent involves antibodies to the cGMP-binding, cGMP-stimulated phosphodiesterase, further showcasing her innovative contributions to the field.
Career Highlights
Throughout her career, Ann has worked with esteemed organizations such as the University of Washington and Icos Corporation. Her research has not only contributed to academic knowledge but has also had practical applications in the biotechnology industry.
Collaborations
Ann has collaborated with notable colleagues, including Joseph A Beavo and Jackie D Corbin. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Ann Kadlecek's work in the field of cyclic GMP-specific phosphodiesterase research exemplifies her dedication to innovation and scientific advancement. Her patents and collaborations highlight her significant role in biochemistry, paving the way for future discoveries.